Literature DB >> 15183786

Medial rectus pulley posterior fixation is as effective as scleral posterior fixation for acquired esotropia with a high AC/A ratio.

Robert A Clark1, Reginald Ariyasu, Joseph L Demer.   

Abstract

PURPOSE: To compare traditional medial rectus (MR) scleral posterior fixation versus MR pulley posterior fixation without scleral sutures for the treatment of acquired esotropia (ET) with a high accommodative convergence over accommodation (AC/A) ratio.
DESIGN: Nonrandomized interventional case series.
METHODS: Medical records were retrospectively reviewed for twenty-two patients who underwent bilateral MR posterior fixation for acquired ET with a high AC/A ratio, with or without associated MR recessions. The main outcome measure was the reduction in distance-near disparity created by MR scleral posterior fixation compared with MR pulley posterior fixation.
RESULTS: Nine patients underwent MR scleral posterior fixation surgery, seven in combination with MR recessions for distance ET. Postoperatively, the distance-near disparity decreased an average of 11.8 prism diopters, stereoacuity improved in six patients, and eight patients no longer needed bifocals. Thirteen patients underwent MR pulley posterior fixation surgery, 10 in combination with MR recessions for distance ET. Postoperatively the distance-near disparity decreased an average of 14.4 prism diopters, stereoacuity improved in eight patients, and 12 patients no longer required bifocals. Statistically, the two procedures were equivalent. One patient in each group was undercorrected at near only, with the residual near ET controlled with bifocals. One patient who underwent MR pulley posterior fixation combined with large MR recessions was overcorrected at distance only.
CONCLUSION: Traditional MR scleral posterior fixation and MR pulley posterior fixation are equally effective in treating acquired ET with a high AC/A ratio.

Entities:  

Mesh:

Year:  2004        PMID: 15183786     DOI: 10.1016/j.ajo.2004.01.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Efficacy of posterior fixation suture augmented with talc or doxycycline.

Authors:  Yeon-Hee Lee; Kwang-Sun Suh; Jeong-Min Hwang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-21       Impact factor: 3.117

2.  Gillies Lecture: ocular motility in a time of paradigm shift.

Authors:  Joseph L Demer
Journal:  Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 4.207

Review 3.  Evidence supporting extraocular muscle pulleys: refuting the platygean view of extraocular muscle mechanics.

Authors:  Joseph L Demer
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2006 Sep-Oct       Impact factor: 1.402

Review 4.  Mechanics of the orbita.

Authors:  Joseph L Demer
Journal:  Dev Ophthalmol       Date:  2007

Review 5.  Distance-near disparity esotropia: can we shrink the gap?

Authors:  J P Burke
Journal:  Eye (Lond)       Date:  2014-11-14       Impact factor: 3.775

Review 6.  Surgical treatment for residual or recurrent strabismus.

Authors:  Tao Wang; Li-Hua Wang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

7.  Magnetic Resonance Imaging of the Globe-Tendon Interface for Extraocular Muscles: Is There an "Arc of Contact"?

Authors:  Robert A Clark; Joseph L Demer
Journal:  Am J Ophthalmol       Date:  2018-07-19       Impact factor: 5.258

8.  Lateral rectus sag and recurrent esotropia in children.

Authors:  Robert A Clark; Andrew E Choy; Joseph L Demer
Journal:  J AAPOS       Date:  2019-02-21       Impact factor: 1.220

9.  Long-term outcome of medial rectus recession and pulley posterior fixation in esotropia with high AC/A ratio.

Authors:  Geoffrey Wabulembo; Joseph L Demer
Journal:  Strabismus       Date:  2012-09

10.  Why bilateral medial rectus recession fails? Factors associated with early repeated surgery.

Authors:  Anat Bachar Zipori; Oriel Spierer; Justin C Sherwin; Lionel Kowal
Journal:  Int Ophthalmol       Date:  2019-08-05       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.